Teva Pharmaceuticals Industries Limited
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Teva Pharmaceuticals Industries Limited (“Teva” or the “Company”) (NYSE: TEVA) securities during the period from October 29, 2015 through August 18, 2020, inclusive (the “Class Period”). Investors have until November 23, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
According to the Complaint, the Company made false and misleading statements to the market. Teva made kickback payments to charities as part of a scheme to cover Medicare co-payments for patients taking Copaxone. A portion of the Company’s Copaxone revenue was derived from this illegal scheme. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Teva, investors suffered damages.
If you acquired Teva securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney at 212-371-6600, by email at firstname.lastname@example.org, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.